FierceBiotech1 天
Novartis 'took data to heart' before slimming clinical pipeline by 40%, says CEO
Novartis has slimmed down its clinical-stage programs by nearly 40% in recent years as the Big Pharma “took to heart” data ...
Human stem cell-derived heart cells are safe in monkeys, could treat congenital heart disease
A research team led by Marina Emborg, professor of medical physics in the UW–Madison School of Medicine and Public Health, ...